PENN STATE COLLEGE OF MEDICINE
PENN STATE CHILDREN'S HOSPITAL
1-800-243-1455
 
 
 
 
Home
 
 
Patient Care
 
 
Education
 
 
Research
 
 
Community
 
 
 
Research » Behavioral Neuroimaging » Publications
 

 

Research
 
 
Behavioral Neuroimaging Research
Publications
  1. Anderson DW, Moore GJ, Lester PD, Absolute kVp Calibration Using Characteristic X-ray Yields, Medical Physics 13, 663-66 (1986).
  2. Jolesz FA, Moore GJ, Mulkern RV, Blier AR, González RG, Bowers J,  Metz K, Higuchi N, Colucci VM, Response to and control of destructive energy with MRI and MRS, Investigative Radiology 24(12), 1024-27 (1989).
  3. Jolesz FA, Blier AR, Higuchi N, Moore GJ, Mulkern RV, Jakab P, Colucci VM, MRI and MRS to monitor and control experimental laser surgery, Biomedical Optics, SPIE Proceedings 1200,73-83 (1990).
  4. Cheng HM, Aguayo JB, Moore GJ, Mattingly MA, Analysis of Diabetic Cataractogenesis using Chemical-Shift Nuclear Magnetic Resonance Microscopy, Magnetic Resonance in Medicine 17, 62-68 (1991).
  5. Moore GJ, Hrovat MI and González RG, Simultaneous Multinuclear Magnetic Resonance Imaging and Spectroscopy, Magnetic Resonance in Medicine 19, 105-12 (1991).
  6. Cheng HM, Kwong KK, Dixon S, Tanaka G, Xiong J, Moore GJ, Chesler DA, Water movement in the rabbit eye: An investigation by deuterium NMR, Experimental Eye Research , 52, 337-1 (1991).
  7. Moore GJ, Sanders JA, Sillerud LO, Zero Quantum Difference Spectroscopy for Strongly Coupled Systems, Journal of Magnetic Resonance-A  104, 111-14 (1993).
  8. Moore GJ and Sillerud LO, The pH Dependence of Chemical Shift and Spin-Spin Coupling for Citrate, Journal of Magnetic Resonance-B  103, 87-88 (1994).
  9. Hammel PC, Zhang Z, Moore GJ, Roukes ML, Sub-surface Imaging with the Magnetic Resonance Force Microscope, Journal of Low Temperature Physics 101, 59-69 (1995).
  10. Zhang Z, Hammel PC, Moore GJ, Application of a Novel Radiofrequency Coil Design to the Magnetic Resonance Force Microscope, Rev. of Sci. Instru., 67:9, 3307-9 (1996).
  11. Yoshizawa T, Nose T, Moore GJ, Sillerud LO, Functional magnetic Resonance Imaging of Motor Activation in the Human Spinal Cord at the Mid-Cervical Level, NeuroImage  4:174-82 (1996).
  12. Watson C, Moore GJ, Chugani HT, Neuroimaging in Epilepsy, The Neurologist 2, 96-118 (1996).
  13. Gonzalez RG, Guimaraes AR , Moore GJ,  Crawley A, Cupples LA,  Growdon JH, Quantitative in vivo 31P magnetic resonance spectroscopy of Alzheimer disease, Alzheimer Disease & Associated Disorders, 10(1):46-52, (1996).
  14. Hu J, Willcott MR, Moore GJ, Two Dimensional Proton Chemical Shift Imaging of Human Muscle Metabolites, Journal Of Magnetic Resonance, 126:187-192 (1997)
  15. Moore GJ, Slovis TL, Chugani HT, Proton Magnetic Resonance Spectroscopy in Children with Sturge-Weber syndrome, Journal of Child Neurology, 13(7): 332-35 (1998).
  16. Moore GJ, McMaster, FP, Stewart C, Rosenberg DR, Case Study: Caudate Glutamatergic Changes With Paroxetine Therapy for Pediatric Obsessive Compulsive Disorder, Journal American Academy of Child and Adolescent Psychiatry, 37(6): 663-67 (1998).
  17. Moore GJ, Proton magnetic resonance spectroscopy in pediatric neuroradiology, Pediatric Radiology , 28:805-14 (1998).
  18. Manji HK, Bebchuk JM, Moore GJ, Glitz D, Hasanat K, Chen G, Modulation of CNS Signal Transduction Pathways and Gene Expression by Mood Stabilizing Agents: Therapeutic Implications, Journal of Clinical Psychiatry, 60(S2): 27-39 (1999).
  19. Chugani DC, Sundram BS, Behen M, Lee ML, Moore GJ, Evidence of Altered Energy Metabolism in Autistic Children, Prog. Neuro-Psychopharmacol. & Biol. Psychiat., 23:635-41  (1999).
  20. Chen G, Hasanat K, Bebchuk JM, Moore GJ, Glitz D,  Manji HK, Regulation of Signal Transduction Pathways and Gene Expression by Mood Stabilizers and Antidepressants, Psychosomatic Medicine, 61:599-17 (1999).
  21. Manji HK, Moore GJ, Chen G, Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?, Biological Psychiatry, 46:929-940 (1999).
  22. Moore GJ, Bebchuk JM, Parrish JK, Faulk MW, Arfken CL, Strahl-Bevacqua J, Manji HK, Temporal Dissociation Between Lithium Induced Frontal Lobe Myo-Inositol Changes and Clinical Response in Manic Depressive Illness, American Journal of Psychiatry, 156(12): 1922-31(1999).
  23. Fitzgerald KD, Moore GJ, Paulson LA, Stewart CM, Rosenberg DR, Proton Spectroscopic Imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder, Biological Psychiatry, 47(3): 174-82 (2000).
  24. Moore GJ, Bebchuk JM,  Hasanat K, Faulk MW, Seraji-Bozorgzad N, Wilds IB, Arfken CL, Chen G, Manji HK Lithium Increases N-acetyl-aspartate in the Human Brain: In Vivo Evidence In Support of bcl-2’s Neurotrophic Effects? Biological Psychiatry, 48(1):1-8, (2000).
  25. Gilbert AR, Moore GJ, Keshavan MS, Paulson LA, Narula V, Mac Master FP, Stewart CM, Rosenberg DR, Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine, Archives of General Psychiatry, 57(5):449-56 (2000).
  26. Pfund Z, Chugani DC, Juhasz C, Muzik O Chugani HT, Wilds IB, Seraji-Bozorgzad N, Moore GJ, Evidence for Coupling Between Glucose Metabolism and Glutamate Cycling Using FDG PET and 1H MRS in Epilepsy, Journal of Cerebral Blood Flow and Metabolism, 20(5):871-8 (2000).
  27. Rosenberg DR, Benazon NR, Gilbert A, Sullivan A and Moore GJ, Thalamic Volume in Pediatric Obsessive Compulsive Disorder Patients Before and After Cognitive Behavioral Therapy, Biological Psychiatry, 48(4):294-300 (2000).
  28. Manji HK, Moore GJ, Chen G, Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness. Journal of Clinical Psychiatry, 61(S9):82-96 (2000).
  29. Rosenberg DR, MacMaster FP, Keshavan MS, Fitzgerald KD, Stewart CM, Moore GJ, Decrease in Caudate Glutamatergic concentrations in Pediatric Obsessive-Compulsive Disorder Patients Taking Paroxetine, Journal  American Academy of Child and Adolescent Psychiatry, 39(9):1096-103 (2000).
  30. Manji HK, Moore GJ, Chen G, Clinical and preclinical evidence for the neurotrophic effects of Mood Stabilizers: implications for the pathophysiology and treatment of manic depressive illness, Biological Psychiatry, 48(8):740-54 (2000).
  31. Manji HK, Moore GJ, Rajkowska G, Chen G, Neuroplasticity And Cellular Resilience in Mood Disorders, Molecular Psychiatry, 5(6):578-93 (2000).
  32. Moore GJ, Bebchuk JM, Wilds IB, Chen G, Manji HK, Lithium-Induced  Increase in Human Brain Grey Matter, Lancet, 356(9237):1241-42 (2000).
  33. Bolton J., Moore GJ, MacMillan S., Stewart CM, and Rosenberg DR (2001) Case study: caudate glutamatergic changes with paroxetine persist after medication discontinuation in pediatric OCD. J Am Acad Child Adolesc Psychiatry 40, 903-906. (2001).
  34. Manji HK, Moore GJ, and Chen G (2001) Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilizers. Br J Psychiatry 178, S107-S119.
  35. Keenan PA, Ezzat WH, Ginsburg K, and Moore GJ (2001) Prefrontal cortex as the site of estrogen's effect on cognition. Psychoneuroendocrinology 26, 577-90.
  36. Rosenberg DR, MacMillan SN, and Moore GJ (2001) Brain anatomy and chemistry may predict treatment response in pediatric obsessive--compulsive disorder. Int J Neuropsychopharmacol 4, 179-90.
  37. Rosenberg DR, Amponsah A, Sullivan A, MacMillan S, Moore GJ. (2001) Increased medial thalamic choline in pediatric obsessive-compulsive disorder as detected by quantitative in vivo spectroscopic imaging J Child Neurol 16(9):636-41.
  38. Garbern JY, Yool DA, Moore GJ, Wilds IB, Faulk MW, Klugmann M, Nave KA, Sistermans EA, van der Knaap MS, Bird TD, Shy ME, Kamholz JA and Griffiths IR (2001) Patients lacking the major CNS myelin protein, Proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 125:551-61 (2002)
  39. Nolan C., Moore G.J., Madden R., Farchione T., Bartoi M., Lorch E., Stewart C.M., Rosenberg D.R (2001) Prefrontal Cortical Volume in Childhood-Onset Major Depression: Preliminary findings Archives General Psychiatry 59(2):173-9 (2002).
  40. Moore GJ, Galloway MP. Magnetic Resonance Spectroscopy: Neurochemistry and Treatment Effects in Affective Disorders. Psychopharmacology Bulletin 36 (2): 5-23 (2002).
  41. Glitz DA, Manji HK, Moore GJ, Mood Disorders: Treatment-induced changes in Brain Neurochemistry and structure, Semin Clin Neuropsychiatry, 7(4):269-80 (2002).
  42. Farchione TR, Moore GJ, Rosenberg DR, Proton Magnetic Resonance Spectroscopic Imaging in Pediatric Major Depression, Biological Psychiatry, 52(2):86-92 (2002).
  43. Manji HK, Zhou R, Moore GJ, Gray N, Du J, Chen G, Genomic Studies Identify novel targets for the long term actions of mood stabilizers, European Neuropsychopharmacology 12:S132-133 (2002).
  44. MacMillan S, Szeszko PR, Moore GJ, Madden R, Lorch E, Ivey J, Banerjee SP, Rosenberg DR. Increased amygdala: hippocampal volume ratios associated with severity of anxiety in pediatric major depression, J Child Adolesc Psychopharmacol. 13(1):65-73 (2003).
  45. Gray NA, Zhou R, Du J, Moore GJ, Manji HK, The use of mood stabilizers as plasticity enhancers in the treatment of neuropsychiatric disorders, Journal of Clinical Psychiatry, 64: S5:3-17 (2003).
  46. Chu A, Alger JR, Moore GJ, Posse S, Proton-Echo-Planar-Spectroscopic-Imaging with Highly Effective Outer Volume Suppression using Combined Presaturation and Spatially Selective Echo Dephasing, Magnetic Resonance in Medicine, 49(5):817-21 (2003).
  47. Posse S, Fitzgerald D, Gao K, Habel U, Rosenberg D, Moore GJ, Schneider F, Real-time Functional Magnetic Resonance Imaging of Temporolimbic Regions Detects Amygdala Activation during Single Trial Self-Induced Sadness, Neuroimage 18(3): 760-768 (2003).
  48. Russell A, Cortese B, Lorch E, Ivey J, Banerjee SP, Moore GJ, Rosenberg DR, Localized functional neurochemical marker abnormalities in dorsolateral prefrontal cortex in pediatric obsessive-compulsive disorder, J Child Adolesc Psychopharmacol, 13 (S1):S31-38 (2003).
  49. Benazon NR, Moore GJ, Rosenberg DR, Neurochemical Analyses in Pediatric Obsessive-Compulsive Disorder in Patients Treated With Cognitive-Behavioral Therapy, J Am Acad Child Adolesc Psychiatry, 42(11):1279-1285 (2003).
  50. Smith EA, Russell A, Lorch E, Banerjee SP, Rose M, Ivey J, Bhandari R, Moore GJ, Rosenberg DR, Increased Medial Thalamic Choline Found in Pediatric Patients with Obsessive-Compulsive Disorder versus Major Depression or Healthy Control Subjects: A Magnetic Resonance Spectroscopy Study, Biological Psychiatry 54(12):1399-405 (2003).
  51. Mirza Y, Tang J, Russell A, Banerjee SP, Bhandari R, Ivey J, Rose M, Moore GJ, Rosenberg DR, Reduced Anterior Cingulate Cortex Glutamatergic Concentrations in Childhood Major Depression, J Am Acad Child Adolesc Psychiatry, 43(3): 341-348 (2004).
  52. Szeszko PR, MacMillan S, McMeniman M, Lorch E, Madden R, Ivey J, Banerjee SP, Moore GJ, Rosenberg DR. Amygdala Volume Reductions in Pediatric Patients with Obsessive-Compulsive Disorder Treated with Paroxetine: Preliminary Findings. Neuropsychopharmacology.29 826-32 (2004).
  53. Szeszko PR, MacMillan S, McMeniman M, Chen S, Baribault K, Lim KO, Ivey J, Rose M, Banerjee SP, Bhandari R, Moore GJ, Rosenberg DR. Brain Structure abnormalities in psychotropic drug-naïve pediatric patients with OCD. Am J Psychiatry. 161(6): 1049-56 (2004).
  54. Phan KL, Fitzgerald D, Gao K, Moore GJ, Tancer ME, Posse S, Real-time fMRI of cortico-limbic brain activity during emotional processing, NeuroReport,  15(3): 527-32 (2004).
  55. Rosenberg DR, Mirza Y, Russell A, Tang J, Smith JM, Banerjee SP, Bhandari R, Rose M, Ivey J, Boyd C, Moore GJ. Reduced anterior cingulated glutamatergic concentrations in childhood OCD and major depression versus healthy controls. J Am Acad Child Adolesc Psychiatry. 43(9): 1146-53 (2004).
  56. Fitzgerald DA, Posse S, Moore GJ, Tancer ME, Nathan PJ, Phan KL. Neural correlates of internally-generated disgust via autobiographical recall: a functional magnetic resonance imaging investigation, Neurosci Lett.Nov 11;370(2-3):91-6. (2004).
  57.  Yuan PX, Gould TD, Gray NA, Bachmann R, Lan M, Du J, Moore GJ, and Manji HK: Neurotrophic signaling cascades are major long-term targets for lithium: clinical implications. Clinical Neuroscience Research,Dec: 4(3-4):13-153. (2004).
  58. Phan KL, Fitzgerald DA, Cortese BM, Seraji-Bozorgzad N, Tancer ME, Moore GJ. Anterior cingulate neurochemistry in social anxiety disorder: 1H-MRS at 4 Tesla.  NeuroReport. 16(2): 183-186 (2005).
  59. Phan KL, Fitzerald DA, Nathan PJ, Moore GJ, Uhde TW, Tancer ME. Neural substrates for voluntary suppression of negative affect: A functional magnetic resonance imaging, Biological Psychiatry, 57(3): 210-219 (2005).